Cytogenetics of lymphomas

References

• Juneja S., Lukeis R., Tan L., et al. Cytogenetic analysis of 147 cases of non‐Hodgkin lymphoma: non‐random chromosomal abnormalities and histological correlations. Br J Haematol 1990; 76: 231–7
   PubMed Web of Science ®Google Scholar
• Harrison C. J. The lymphomas and chronic lymphoid leukaemias. Human Cytogenetics: Malignancy and Acquired Abnormalities 3, D. E Rooney. Oxford University Press, Oxford 2001
   Google Scholar
• Kearney L. The impact of the new FISH technologies on the cytogenetics of haematological malignancies. Br J Haematol 1999; 104: 648–58
   PubMed Web of Science ®Google Scholar
• Paternoster S. F., Brockman S. R., McClure R. F., Remstein E. D., Kurtin P. J., Dewald G. W. A new method to extract nuclei from paraffin‐embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am J Pathol 2002; 160: 1967–72
   PubMed Web of Science ®Google Scholar
• Schurter M. J., LeBrun D. P., Harrison K. J. Improved technique for fluorescence in situ hybridization analysis of isolated nuclei from archival, B5 or formalin fixed, paraffin wax embedded tissue. J Clin Pathol 2002; 55: 121–4
   PubMed Web of Science ®Google Scholar
• Speicher M. R., Ballard S. G., Ward D. C. Karyotyping human chromosomes by combinatorial multi‐fluorescence FISH. Nat Genet 1996; 12: 368–75
   PubMed Web of Science ®Google Scholar
• Schröck E., du Manoir S., Veldman T., et al. Multicolor spectral karyotyping of human chromosomes. Science 1996; 273: 494–7
   PubMed Web of Science ®Google Scholar
• Nanjangud G., Rao P. H., Hegde A., et al. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B‐cell lymphoma. Blood 2002; 99: 2554–61
   PubMed Web of Science ®Google Scholar
• Dalla‐Favera R., Bregni M., Erikson J., Patterson D., Gallo R. C., Croce C. M. Human c‐myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982; 79: 7824–7
   PubMed Web of Science ®Google Scholar
• Namiki T., Sakashita A., Kobayashi H., et al. Clinical and genetic characteristics of Japanese Burkitt lymphomas with or without leukemic presentation. Int J Hematol 2003; 77: 490–8
   PubMed Web of Science ®Google Scholar
• Lones M. A., Sanger W. G., Le Beau M. M., et al. Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt‐like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG‐E08. J Pediatr Hematol Oncol 2004; 26: 169–78
   PubMed Web of Science ®Google Scholar
• Garcia J. L., Hernandez J. M., Gutierrez N. C., et al. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study. Leukemia 2003; 17: 2016–24
   PubMed Web of Science ®Google Scholar
• Barth T. F., Muller S., Pawlita M., et al. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B‐cell lymphoma with MYC rearrangement. J Pathol 2004; 203: 940–5
   PubMed Web of Science ®Google Scholar
• Au W. Y., Horsman D. E., Gascoyne R. D., Viswanatha D. S., Klasa R. J., Connors J. M. The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 2004; 45: 519–28
   PubMed Web of Science ®Google Scholar
• Merchant S., Schlette E., Sanger W., Lai R., Medeiros L. J. Mature B‐cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma‐type chromosomal translocations involving c‐myc. Arch Pathol Lab Med 2003; 127: 305–9
   PubMed Web of Science ®Google Scholar
• Kuriakose P., Perveen N., Maeda K., Wiktor A., Van Dyke D. L. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B‐cell prolymphocytic leukemia. Cancer Genet Cytogenet 2004; 150: 156–8
   PubMedGoogle Scholar
• Jaffe E. S., Harris N. L., Stein H., Vardiman J. W, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001
   Google Scholar
• Pienkowska‐Grela B., Witkowska A., Grygalewicz B., et al. Frequent aberrations of chromosome 8 in aggressive B‐cell non‐Hodgkin lymphoma. Cancer Genet Cytogenet 2005; 156: 114–21
   PubMedGoogle Scholar
• Braziel R. M., Arber D. A., Slovak M. L., et al. The Burkitt‐like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic and clinical features. Blood 2001; 97: 3713–20
   PubMed Web of Science ®Google Scholar
• Cigudosa J. C., Parsa N. Z., Louie D. C., et al. Cytogenetic analysis of 363 consecutively ascertained diffuse large B‐cell lymphomas. Genes Chromosomes Cancer 1999; 25: 123–33
   PubMed Web of Science ®Google Scholar
• Barrans S. L., Evans P. A., O'Connor S. J., et al. The t(14;18) is associated with germinal center‐derived diffuse large B‐cell lymphoma and is a strong predictor of outcome. Clin Cancer Res 2003; 9: 2133–9
   PubMed Web of Science ®Google Scholar
• Huang J. Z., Sanger W. G., Greiner T. C., et al. The t(14;18) defines a unique subset of diffuse large B‐cell lymphoma with a germinal center B‐cell gene expression profile. Blood 2002; 99: 2285–90
   PubMed Web of Science ®Google Scholar
• Monni O., Joensuu H., Franssila K., Klefstrom J., Alitalo K., Knuutila S. BCL2 overexpression associated with chromosomal amplification in diffuse large B‐cell lymphoma. Blood 1997; 90: 1168–74
   PubMed Web of Science ®Google Scholar
• Hirose Y., Masaki Y., Karasawa H., et al. Incidence of diffuse large B‐cell lymphoma of germinal center B‐cell origin in whole diffuse large B‐cell lymphoma: tissue fluorescence in situ hybridization using t(14;18) compared with immunohistochemistry. Int J Hematol 2005; 81: 48–57
   PubMed Web of Science ®Google Scholar
• Iqbal J., Sanger W. G., Horsman D. E., et al. BCL2 translocation defines a unique tumor subset within the germinal center B‐cell‐like diffuse large B‐cell lymphoma. Am J Pathol 2004; 165: 159–66
   PubMed Web of Science ®Google Scholar
• Ueda C., Akasaka T., Kurata M., et al. The gene for interleukin‐21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B‐cell lymphoma. Oncogene 2002; 21: 368–76
   PubMed Web of Science ®Google Scholar
• Jardin F., Buchonnet G., Parmentier F., et al. Follicle center lymphoma is associated with significantly elevated levels of BCL6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements. Leukemia 2002; 16: 2318–25
   PubMed Web of Science ®Google Scholar
• Offit K., Lo Coco F., Louie D. C., et al. Rearrangement of the bcl‐6 gene as a prognostic marker in diffuse large‐cell lymphoma. N Engl J Med 1994; 331: 74–80
   PubMed Web of Science ®Google Scholar
• Barrans S. L., O'Connor S. J. M., Evans P. A. S., et al. Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B‐cell lymphoma. Br J Haematol 2002; 117: 322–32
   PubMed Web of Science ®Google Scholar
• Jerkeman M., Johansson B., Akerman M., Cavallin‐Stahl E., Kristoffersson U., Mitelman F. Prognostic implications of cytogenetic aberrations in diffuse large B‐cell lymphomas. Eur J Haematol 1999; 62: 184–90
   PubMed Web of Science ®Google Scholar
• Vitolo U., Gaidano G., Botto B., et al. Rearrangements of bcl‐6, bcl‐2, c‐myc and 6q deletion in B‐diffuse large‐cell lymphoma: clinical relevance in 71 patients. Ann Oncol 1998; 9: 55–61
   PubMed Web of Science ®Google Scholar
• Akasaka T., Akasaka H., Ueda C., et al. Molecular and clinical features of non‐Burkitt's, diffuse large‐cell lymphoma of B‐cell type associated with the c‐MYC/immunoglobulin heavy‐chain fusion gene. J Clin Oncol 2000; 18: 510–8
   PubMed Web of Science ®Google Scholar
• Kramer M. H. H., Hermans J., Wijburg E., et al. Clinical relevance of BCL2, BCL6 and MYC rearrangements in diffuse large B‐cell lymphoma. Blood 1998; 92: 3152–62
   PubMed Web of Science ®Google Scholar
• Rao P. H., Houldsworth J., Dyomina K., et al. Chromosomal and gene amplification in diffuse large B‐cell lymphoma. Blood 1998; 92: 234–40
   PubMed Web of Science ®Google Scholar
• Bea S., Colomo L., Lopez‐Guillermo A., et al. Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B‐cell lymphomas. J Clin Oncol 2004; 22: 3498–506
   PubMed Web of Science ®Google Scholar
• Vega F., Orduz R., Medeiros L. J. Chromosomal translocations and their role in the pathogenesis of non‐Hodgkins's lymphomas. Pathology 2002; 34: 397–409
   PubMed Web of Science ®Google Scholar
• Yoshioka T., Miura I., Kume M., et al. Cytogenetic features of de novo CD5‐positive diffuse large B‐cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival. Genes Chromosomes Cancer 2005; 42: 149–57
   PubMed Web of Science ®Google Scholar
• Younes A., Pugh W., Goodacre A., et al. Polysomy of chromosome 12 in 60 patients with non‐Hodgkin lymphoma assessed by fluorescence in situ hybridization: differences between follicular and diffuse large cell lymphoma. Genes Chromosome Cancer 1994; 9: 161–7
   PubMed Web of Science ®Google Scholar
• Rosenwald A., Wright G., Chan W. C., et al. ; Lymphoma/Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large‐B‐cell lymphoma. N Engl J Med 2002; 346: 1937–47
   PubMed Web of Science ®Google Scholar
• Bentley G., Palutke M., Mohamed A. N. Variant t(14;18) in malignant lymphoma: a report of seven cases. Cancer Genet Cytogenet 2005; 157: 12–7
   PubMed Web of Science ®Google Scholar
• Guo Y., Karube K., Kawano R., et al. Low‐grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia 2005; 19: 1058–63
   PubMed Web of Science ®Google Scholar
• Elenitoba‐Johnson K. S. J., Gascoyne R. D., Lim M. S., Chhanabai M., Jaffe E. S., Raffeld M. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 1998; 91: 4677–85
   PubMed Web of Science ®Google Scholar
• Horsman D. E., Connors J. M., Pantzar T., Gascoyne R. D. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 2001; 30: 375–82
   PubMed Web of Science ®Google Scholar
• Aamot H., Micci F., Holte H., Delabie J., Heim S. M‐FISH cytogenetic analysis of non‐Hodgkin lymphomas with t(14;18)(q32;q21) and add(1)(p36) as a secondary abnormality shows that the extra material often comes from chromosome arm 17q. Leuk Lymphoma 2002; 43: 1051–6
   PubMed Web of Science ®Google Scholar
• Ladanyi M., Offit K., Parsa N. Z., et al. Follicular lymphoma with t(8;14)(q24;q32): a distinct clinical and molecular subset of t(8;14)‐bearing lymphomas. Blood 1992; 79: 2124–30
   PubMed Web of Science ®Google Scholar
• Mohamed A. N., Palutke M., Eisenberg L., Al‐Katib A. Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant. Cancer Genet Cytogenet 2001; 126: 45–51
   PubMedGoogle Scholar
• Ott G., Katzenberger T., Lohr A., et al. Cytomorphologic, immunohistochemical and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002; 99: 3806–12
   PubMed Web of Science ®Google Scholar
• Bosga‐Bouwer A. G., van Imhoff G. W., Boonstra R., et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27 or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood 2003; 101: 1149–54
   PubMed Web of Science ®Google Scholar
• Hernandez J. M., Mecucci C., Criel A., et al. Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia 1995; 9: 2140–6
   PubMed Web of Science ®Google Scholar
• Matutes E., Oscier D., Garcia‐Marco J., et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92: 382–8
   PubMed Web of Science ®Google Scholar
• Michaux L., Dierlamm J., Wlodarska I., Bours V., Van den Berghe H., Hagemeijer A. t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. Cancer Genet Cytogenet 1997; 94: 36–43
   PubMed Web of Science ®Google Scholar
• Michaux L., Wlodarska I., Rack K., et al. Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ‘unmutated’ B‐CLL. Leukemia 2005; 19: 77–82
   PubMed Web of Science ®Google Scholar
• Dohner H., Stilgenbauer S., Benner A., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–6
   PubMed Web of Science ®Google Scholar
• Krober A., Seiler T., Benner A., et al. V, H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410–6
   PubMed Web of Science ®Google Scholar
• Oscier D. G., Gardiner A. C., Mould S. J., et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177–84
   PubMed Web of Science ®Google Scholar
• Guarini A., Gaidano G., Mauro F. R., et al. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 2003; 102: 1035–41
   PubMed Web of Science ®Google Scholar
• Jahrsdörfer B., Wooldridge J. E., Blackwell S. E., Taylor C. M., Link B. K., Weiner G. J. Good prognosis cytogenetics in B‐cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity. Leukemia 2005; 19: 759–66
   PubMed Web of Science ®Google Scholar
• Byrd J. C., Smith L., Hackbarth M. L., et al. Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab. Cancer Res 2003; 63: 36–8
   PubMed Web of Science ®Google Scholar
• Streubel B., Lamprecht A., Dierlamm J., et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003; 101: 2335–9
   PubMed Web of Science ®Google Scholar
• Maes B., Demunter A., Peeters B., De Wolf‐Peeters C. BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT‐type lymphoma, and the presence of the AP12‐MLT fusion is associated with aberrant nuclear BCL10 expression. Blood 2002; 99: 1398–404
   PubMed Web of Science ®Google Scholar
• Streubel B., Vinatzer U., Lamprecht A., Raderer M., Chott A. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005; 19: 652–8
   PubMed Web of Science ®Google Scholar
• Streubel B., Simonitsch‐Klupp I., Mullauer L., et al. Variable frequencies of MALT lymphoma‐associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18: 1722–6
   PubMed Web of Science ®Google Scholar
• Remstein E. D., Kurtin P. J., James C. D., Wang X. ‐. Y., Meyer R. G., Dewald G. W. Mucosa‐associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa‐associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol 2002; 161: 63–71
   PubMed Web of Science ®Google Scholar
• Liu H., Ye H., Dogan A., et al. t(11;18)(q21;q21) is associated with advanced mucosa‐associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001; 98: 1182–7
   PubMed Web of Science ®Google Scholar
• Liu H., Ye H., Ruskone‐Fourmestraux A., et al. t(11;18) is a marker for all gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286–94
   PubMed Web of Science ®Google Scholar
• Starostik P., Patzner J., Greiner A., et al. Gastric marginal zone B‐cell lymphomas of MALT type develop along two distinct pathogenetic pathways. Blood 2002; 99: 3–9
   PubMed Web of Science ®Google Scholar
• Mateo M., Mollejo M., Villuendas R., et al. 7q31–32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol 1999; 154: 1583–9
   PubMed Web of Science ®Google Scholar
• Chacon J. I., Mollejo M., Munoz E., et al. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 2002; 100: 1648–54
   PubMed Web of Science ®Google Scholar
• Belaud‐Rotureau M. A., Parrens M., Dubus P., Garroste J. C., de Mascarel A., Merlio J. P. A comparative analysis of FISH, RT‐PCR, PCR and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol 2002; 15: 517–25
   PubMed Web of Science ®Google Scholar
• Sun T., Nordberg M. L., Cotelingam J. D., Veillon D. M., Ryder J. Fluorescence in situ hybridization: method of choice for a definitive diagnosis of mantle cell lymphoma. Am J Hematol 2003; 74: 78–84
   PubMed Web of Science ®Google Scholar
• Ruchlemer R., Parry‐Jones N., Brito‐Babapulle V., et al. B‐prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia. Br J Haematol 2004; 125: 330–6
   PubMed Web of Science ®Google Scholar
• Bjorck E., Landgren O., Schoumans J., et al. Molecular cytogenetic approach to the diagnosis of splenic lymphoma: a case report of blastoid mantle cell lymphoma. Leuk Lymphoma 2003; 44: 1229–34
   PubMed Web of Science ®Google Scholar
• Maravelaki S., Burford A., Wotherspoon A., et al. Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region. Cancer Genet Cytogenet 2004; 154: 67–71
   PubMed Web of Science ®Google Scholar
• Mohamed A. N., Ali W., Kopptich F., al Katib A. Banded chromosomes versus fluorescence in situ hybridization in the diagnosis of mantle cell lymphoma: a lesson from three cases. Cancer Genet Cytogenet 2002; 136: 108–12
   PubMedGoogle Scholar
• Aventin A., Nomdedeu J., Briones J., Espinosa I., Bordes R., Sierra J. Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14. J Clin Pathol 2003; 56: 798–800
   PubMed Web of Science ®Google Scholar
• Au W. Y., Gascoyne R. D., Viswanatha D. S., Connors J. M., Klasa R. J., Horsman D. E. Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases. Leuk Lymphoma 2002; 43: 783–91
   PubMed Web of Science ®Google Scholar
• Bertoni F., Conconi A., Cogliatti S. B., et al. ; Swiss Group for Clinical Cancer Research. Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22–23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research. Br J Haematol 2004; 124: 289–98
   PubMed Web of Science ®Google Scholar
• Woroniecka R., Pienkowska‐Grela B., Grygalewicz B., et al. Significance of chromosomal markers in the diagnosis of mantle cell lymphoma (MCL). J Appl Genet 2002; 43: 545–53
   PubMedGoogle Scholar
• Hao S., Sanger W., Onciu M., Lai R., Schlette E. J., Medeiros L. J. Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol 2002; 15: 1266–72
   PubMed Web of Science ®Google Scholar
• Vaishampayan U. N., Mohamed A. N., Dugan M. C., Bloom R. E., Palutke M. Blastic mantle cell lymphoma associated with Burkitt‐type translocation and hypodiploidy. Br J Haematol 2001; 115: 66–8
   PubMed Web of Science ®Google Scholar
• Michaux L., Wlodarska I., Theate I., et al. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome. Ann Hematol 2004; 83: 578–83
   PubMed Web of Science ®Google Scholar
• Felten C. L., Stephenson C. F., Ortiz R. O., Hertzberg L. Burkitt transformation of mantle cell lymphoma. Leuk Lymphoma 2004; 45: 2143–7
   PubMed Web of Science ®Google Scholar
• Nagy B., Lundan T., Larramendy M. L., et al. Abnormal expression of apoptosis‐related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma. Br J Haematol 2003; 120: 434–41
   PubMed Web of Science ®Google Scholar
• Khoury J. D., Sen F., Abruzzo L. V., Hayes K., Glassman A., Medeiros L. J. Cytogenetic findings in blastoid mantle cell lymphoma. Hum Pathol 2003; 34: 1022–9
   PubMed Web of Science ®Google Scholar
• Monni O., Oinonen R., Elonen E., et al. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer 1998; 21: 298–307
   PubMed Web of Science ®Google Scholar
• Allen J. E., Hough R. E., Goepel J. R., et al. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. Br J Haematol 2002; 116: 291–8
   PubMed Web of Science ®Google Scholar
• Solenthaler M., Matutes E., Brito‐Babapulle V., Morilla R., Catovsky D. p53 and mdm2 in mantle cell lymphoma in leukemic phase. Haematologica 2002; 87: 1141–50
   PubMed Web of Science ®Google Scholar
• Schraders M., Pfundt R., Straatman H. M., et al. Novel chromosomal imbalances in mantle cell lymphoma detected by genome‐wide array‐based comparative genomic hybridization. Blood 2005; 105: 1686–93
   PubMed Web of Science ®Google Scholar
• Wlodarska I., Meeus P., Stul M., et al. Variant t(2;11)(p11;q13) associated with the IgK‐CCND1 rearrangement is a recurrent translocation in leukemic small‐cell B‐non‐Hodgkin lymphoma. Leukemia 2004; 18: 1705–10
   PubMed Web of Science ®Google Scholar
• Orchard J., Garand R., Davis Z., et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 2003; 101: 4975–81
   PubMed Web of Science ®Google Scholar
• Nodit L., Bahler D. W., Jacobs S. A., Locker J., Swerdlow S. H. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol 2003; 34: 1030–4
   PubMed Web of Science ®Google Scholar
• Lima M., Pinto L., Dos Anjos Teixeira M., et al. Guess what: Chronic 13q14.3+/CD5−/CD23+ lymphocytic leukemia in blood and t(11;14)(q13;q32)+/CD5+/CD23− mantle cell lymphoma in lymph nodes!. Cytometry B Clin Cytom 2003; 51: 41–4
   PubMed Web of Science ®Google Scholar
• Bentz J. S., Rowe L. R., Anderson S. R., Gupta P. K., McGrath C. M. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material. Cancer 2004; 102: 124–31
   PubMed Web of Science ®Google Scholar
• Palka G., Spadano A., Geraci L., et al. Chromosome changes in 19 patients with Waldenström's macroglobulinemia. Cancer Genet Cytogenet 1987; 29: 261–9
   PubMed Web of Science ®Google Scholar
• Offit K., Parsa N. Z., Filippa D., Jhanwar S. C., Chaganti R. S. t(9;14)(p13;q32) denotes a subset of low‐grade non‐Hodgkin lymphoma with plasmacytoid differentiation. Blood 1992; 80: 2594–9
   PubMed Web of Science ®Google Scholar
• Schop R. F., Kuehl W. M., Van Wier S. A., et al. Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood 2002; 100: 2996–3001
   PubMed Web of Science ®Google Scholar
• Cook J. R., Aguilera N. I., Reshmi‐Skarja S., et al. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Hum Pathol 2004; 35: 447–54
   PubMed Web of Science ®Google Scholar
• Wong K. F., So C. C., Chan J. C., Kho B. C., Chan J. K. Gain of chromosome 3/3q in B‐cell chronic lymphoproliferative disorder is associated with plasmacytoid differentiation with or without IgM overproduction. Cancer Genet Cytogenet 2002; 136: 82–5
   PubMedGoogle Scholar
• Michaux L., Dierlamm J., Wlodarska I., et al. Trisomy 3 is a consistent chromosome change in malignant lymphoproliferative disorders preceded by cold agglutinin disease. Br J Haematol 1995; 91: 421–4
   PubMed Web of Science ®Google Scholar
• Kluin‐Nelemans H. C., Beverstock G. C., Mollevanger P., et al. Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 1994; 84: 3134–41
   PubMed Web of Science ®Google Scholar
• Dierlamm J., Stefanova M., Wlodarska I., et al. Chromosomal gains and losses are uncommon in hairy cell leukemia: a study based on comparative genomic hybridization and interphase fluorescence in situ hybridization. Cancer Genet Cytogenet 2001; 128: 164–7
   PubMedGoogle Scholar
• Sambani C., Trafalis D. T. P., Mitsoulis‐Mentzikoff C., et al. Clonal chromosome rearrangements in hairy cell leukemia: personal experience and review of the literature. Cancer Genet Cytogenet 2001; 129: 138–44
   PubMedGoogle Scholar
• Schouten H. C., Sanger W. G., Duggan M., Weisenburger D. D., MacLennan K. A., Armitage J. O. Chromosomal abnormalities in Hodgkin disease. Blood 1989; 73: 2149–54
   PubMed Web of Science ®Google Scholar
• Pedersen R. K., Sorensen A. G., Pedersen N. T., Schmidt K. G., Kerndrup G. B. Chromosome aberrations in adult Hodgkin disease in a Danish population‐based study. Cancer Genet Cytogenet 1999; 110: 128–32
   PubMedGoogle Scholar
• Atkin N. B. Cytogenetics of Hodgkin disease. Cytogenet Cell Genet 1998; 80: 23–7
   PubMedGoogle Scholar
• Falzetti D., Crescenzi B., Matteuci C., et al. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin disease. Haematologica 1999; 84: 298–305
   PubMed Web of Science ®Google Scholar
• Gupta R. K., Lister T. A., Bodmer J. G. The t(14;18) chromosomal translocation and Bcl‐2 protein expression in Hodgkin disease. Leukemia 1994; 8: 1337–41
   PubMed Web of Science ®Google Scholar
• Wlodarska I., Nooyen P., Maes B., et al. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 2003; 101: 706–10
   PubMed Web of Science ®Google Scholar
• Ohshima K., Haraoka S., Yoshioka S., et al. Chromosome 16q deletion and loss of E‐cadherin expression in Hodgkin and Reed‐Sternberg cells. Int J Cancer 2001; 92: 678–82
   PubMed Web of Science ®Google Scholar
• Kupper M., Joos S., von Bonin F., et al. MDM2 gene amplification and lack of p53 point mutations in Hodgkin and Reed‐Sternberg cells: results from single‐cell polymerase chain reaction and molecular cytogenetic studies. Br J Haematol 2001; 112: 768–75
   PubMed Web of Science ®Google Scholar
• Joos S., Menz C. K., Wrobel G., et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002; 99: 1381–7
   PubMed Web of Science ®Google Scholar
• Jansen M. P., Hopman A. H., Bot F. J., et al. Morphologically normal, CD30‐negative B‐lymphocytes with chromosome aberrations in classical Hodgkin disease: the progenitor cell of the malignant clone?. J Pathol 1999; 189: 527–32
   PubMed Web of Science ®Google Scholar
• Jansen M. P., Hopman A. H., Haesevoets A. M., et al. Chromosomal abnormalities in Hodgkin disease are not restricted to Hodgkin/Reed‐Sternberg cells. J Pathol 1998; 185: 145–52
   PubMed Web of Science ®Google Scholar
• Bentz M., Barth T. F., Bruderlein S., et al. Gain of chromosome arm 9p is characteristic of primary mediastinal B‐cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer 2001; 30: 393–401
   PubMed Web of Science ®Google Scholar
• Hallermann C., Kaune K. M., Gesk S., et al. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B‐cell lymphomas. J Invest Dermatol 2004; 123: 213–9
   PubMed Web of Science ®Google Scholar
• Berger R., Baranger L., Bernheim A., Valensi F., Flandrin G. Cytogenetics of T‐cell malignant lymphoma. Report of 17 cases and review of the chromosomal breakpoints. Cancer Genet Cytogenet 1988; 36: 123–30
   PubMed Web of Science ®Google Scholar
• Schlegelberger B., Zhang Y., Weber‐Matthiesen K., Grote W. Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia‐type T‐cell lymphoma by combined interphase and metaphase cytogenetics. Blood 1994; 84: 2640–8
   PubMed Web of Science ®Google Scholar
• Schlegelberger B., Zwingers T., Hohenadel K., et al. Significance of cytogenetic findings for the clinical outcome in patients with T‐cell lymphoma of angioimmunoblastic lymphadenopathy type. J Clin Oncol 1996; 14: 593–9
   PubMed Web of Science ®Google Scholar
• Gesk S., Martin‐Subero J. I., Harder L., et al. Molecular cytogenetic detection of chromosomal breakpoints in T‐cell receptor gene loci. Leukemia 2003; 17: 738–45
   PubMed Web of Science ®Google Scholar
• Schlegelberger B., Himmler A., Godde E., Grote W., Feller A. C., Lennert K. Cytogenetic findings in peripheral T‐cell lymphomas as a basis for distinguishing low‐grade and high‐grade lymphomas. Blood 1994; 83: 505–11
   PubMed Web of Science ®Google Scholar
• Thangavelu M., Finn W. G., Yelavarthi K. K., et al. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sezary syndrome. Blood 1997; 89: 3371–7
   PubMed Web of Science ®Google Scholar
• Espinet B., Salido M., Pujol R. M., et al. Genetic characterization of Sezary's syndrome by conventional cytogenetics and cross‐species color banding fluorescent in situ hybridization. Haematologica 2004; 89: 165–73
   PubMed Web of Science ®Google Scholar
• Mao X., Lillington D., Scarisbrick J. J., et al. Molecular cytogenetic analysis of cutaneous T‐cell lymphomas: identification of common genetic alterations in Sezary syndrome and mycosis fungoides. Br J Dermatol 2002; 147: 464–75
   PubMed Web of Science ®Google Scholar
• Brito‐Babapulle V., Pomfret M., Matutes E., Catovsky D. Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia. Blood 1987; 70: 926–31
   PubMed Web of Science ®Google Scholar
• Pekarsky Y., Hallas C., Isobe M., Russo G., Croce C. M. Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes. Proc Natl Acad Sci USA 1999; 96: 2949–51
   PubMed Web of Science ®Google Scholar
• Kamada N., Sakurai M., Miyamoto K., et al. Chromosome abnormalities in adult T‐cell leukemia/lymphoma: a karyotype review committee report. Cancer Res 1992; 52: 1481–93
   PubMed Web of Science ®Google Scholar
• Tsukasaki K., Krebs J., Nagai K., et al. Comparative genomic hybridization analysis in adult T‐cell leukemia/lymphoma: correlation with clinical course. Blood 2001; 97: 3875–81
   PubMed Web of Science ®Google Scholar
• Morris S. W., Xue L., Ma Z., Kinney M. C. Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non‐Hodgkin lymphoma. Br J Haematol 2001; 113: 275–95
   PubMed Web of Science ®Google Scholar
• Tort F., Pinyol M., Pulford K., et al. Molecular characterisation of a new ALK translocation involving Moesin (MSN‐ALK) in anaplastic large cell lymphoma. Lab Invest 2001; 81: 419–26
   PubMed Web of Science ®Google Scholar
• Lamant L., Gascoyne R. D., Duplantier M. M., et al. Non‐muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma. Genes Chromosomes Cancer 2003; 37: 427–32
   PubMed Web of Science ®Google Scholar
• Gascoyne R. D., Lamant L., Martin‐Subero J. I., et al. ALK‐positive diffuse large B‐cell lymphoma is associated with Clathrin‐ALK rearrangements: report of 6 cases. Blood 2003; 102: 2568–73
   PubMed Web of Science ®Google Scholar
• Liang X., Meech S. J., Odom L. F., et al. Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma. Am J Clin Pathol 2004; 121: 496–506
   PubMed Web of Science ®Google Scholar
• Macdonald D., Reiter A., Cross N. C. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 2002; 107: 101–7
   PubMed Web of Science ®Google Scholar
• Zettl A., Ott G., Makulik A., et al. Chromosomal gains at 9q characterize enteropathy‐type T‐cell lymphoma. Am J Pathol 2002; 161: 1635–45
   PubMed Web of Science ®Google Scholar
• Cejkova P., Zettl A., Baumgartner A. K., et al. Amplification of NOTCH1 and ABL1 gene loci is a frequent aberration in enteropathy‐type T‐cell lymphoma. Virchows Arch 2005; 446: 416–20
   PubMed Web of Science ®Google Scholar
• Suzuki R., Suzumiya J., Nakamura S., et al. ; NK‐cell Tumor Study Group. Aggressive natural killer‐cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia 2004; 18: 763–70
   PubMed Web of Science ®Google Scholar
• Dhodapkar M. V., Li C. Y., Lust J. A., Tefferi A., Phyliky R. L. Clinical spectrum of clonal proliferations of T‐large granular lymphocytes: a T‐cell clonopathy of undetermined significance?. Blood 1994; 84: 1620–7
   PubMed Web of Science ®Google Scholar
• Wong K. F., Chan J. C., Liu H. S., Man C., Kwong Y. L. Chromosomal abnormalities in T‐cell large granular lymphocyte leukaemia: report of two cases and review of the literature. Br J Haematol 2002; 116: 598–600
   PubMed Web of Science ®Google Scholar
• Leroux D., Mugneret F., Callanan M., et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood 2002; 99: 4154–9
   PubMed Web of Science ®Google Scholar
• Hallermann C., Middel P., Griesinger F., Gunawan B., Bertsch H. P., Neumann C. CD4+ CD56+ blastic tumor of the skin: cytogenetic observations and further evidence of an origin from plasmocytoid dendritic cells. Eur J Dermatol 2004; 14: 317–22
   PubMed Web of Science ®Google Scholar
• Cook J. R., Shekhter‐Levin S., Swerdlow S. H. Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies. Am J Clin Pathol 2004; 121: 826–35
   PubMed Web of Science ®Google Scholar